Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lava Therapeutics N.V. (NQ: LVTX ) 2.100 +0.030 (+1.45%) Streaming Delayed Price Updated: 9:30 AM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,347 Open 2.100 Bid (Size) 2.100 (9) Ask (Size) 2.150 (1) Prev. Close 2.070 Today's Range 2.100 - 2.100 52wk Range 1.131 - 6.470 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference June 20, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire LAVA Announces Annual Meeting of Shareholders June 10, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Performance YTD +19.80% +19.80% 1 Month +16.67% +16.67% 3 Month -27.59% -27.59% 6 Month +15.38% +15.38% 1 Year +11.70% +11.70% More News Read More LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference May 30, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire What 5 Analyst Ratings Have To Say About LAVA Therapeutics August 23, 2023 Via Benzinga LVTX Stock Earnings: LAVA Therapeutics Beats EPS, Misses Revenue for Q1 2024 May 21, 2024 Via InvestorPlace LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results May 21, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference May 06, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire LVTX Stock Earnings: LAVA Therapeutics Misses EPS, Misses Revenue for Q4 2023 March 20, 2024 Via InvestorPlace LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results March 20, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments March 05, 2024 Via FinancialNewsMedia Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments March 05, 2024 From FN Media Group LLC Via GlobeNewswire LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223) March 05, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI January 29, 2024 Via AB Newswire Topics Retirement Exposures Pension Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet (Donald Trump Has Re-Entered The Chat) January 26, 2024 Via Benzinga Topics Government Exposures Political Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 26, 2024 Via InvestorPlace Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results January 25, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 25, 2024 Via Benzinga Dow Surges Over 100 Points; US GDP Growth Tops Estimates January 25, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today? January 25, 2024 Via Benzinga LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA® January 25, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results November 16, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire LAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference September 06, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire LAVA Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results August 22, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire LAVA Therapeutics to Participate in the H.C. Wainwright Immune Cell Engager Virtual Conference August 14, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire LAVA Therapeutics Provides Updates on Clinical Programs and Extends the Cash Runway June 14, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
